Clinical Trials List
Protocol Number87801493LYM1001
NCT Number(ClinicalTrials.gov Identfier)-
Completed
2025-08-01 - 2025-09-09
Phase I
Terminated2
-
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/08
Investigators and Locations
Co-Principal Investigator
- 王幸婷 Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Tai-Chung Huang
Co-Principal Investigator
- 田豐銘 Division of General Internal Medicine
- 李思慧 Division of Family Medicine
- Wen-Chien Chou Division of Others -
- Chien-Chin Lin Division of Others -
- HSIN-AN HOU Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- 袁章祖 Division of Others
- Huai-Hsuan Huang Division of General Internal Medicine
- 楊鎰聰 Division of Radiology
- 劉高郎 Division of General Internal Medicine
- Chieh-Lung Cheng Division of Nuclear Medicine
- MEI-FANG CHENG
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
140 participants
